PROSTIN VR® Principal Display Panel (alprostadil) | Pfizer Medical Information

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 mL Ampoule Label

1 mL NDC 0009-3169-01 Rx only

Prostin VR Pediatric®
alprostadil injection, USP
500 mcg*
FOR INTRAVASCULAR USE ONLY

Refrigerate at 2° to 8°C (36° to 46°F).

DOSAGE AND USE:

See accompanying prescribing
information. Dilute before using.

*Each mL contains: 500 micrograms
alprostadil in dehydrated alcohol.

Distributed by Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017
MADE IN USA (includes foreign content)

11123001

FPO: RSS

LOT

EXP

PRINCIPAL DISPLAY PANEL - 1 mL Ampoule Label

PRINCIPAL DISPLAY PANEL - 5—1 mL Ampoule Package

NDC 0009-3169-06
Contains 5 of NDC 0009-3169-01
Rx only

5—1 mL Ampoules

Prostin VR
Pediatric®
alprostadil injection, USP

500 mcg*

FOR INTRAVASCULAR USE ONLY

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 5—1 mL Ampoule Package

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PROSTIN VR® Quick Finder

Stability Calculator
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

WARNING

Apnea is experienced by about 10 to 12% of neonates with congenital heart defects treated with PROSTIN VR PEDIATRIC Sterile Solution. Apnea is most often seen in neonates weighing less than 2 kg at birth and...